GL
GLUE
Monte Rosa Therapeutics, Inc.
10.76
-1.01%
2026-10-30
Last 90d 1 insider sale
52-week range
9.68
25.77
1-month-4.4%
3-month-30.0%
1-year-13.9%
3-year+330.4%
5-year-52.8%
vs 50-day-10.9%
vs 200-day-38.1%
Volatility81%
Beta0.93
$ vol/day$16M
ATH45.56
From ATH-76.4%
Next report2026-11-05
Nothing written about GLUE yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 25d | sell | 1 | $137 | 10.08 | |
| 3mo | sell | 1 | $220,219 | 23.41 | |
| 4mo | sched | 1 | $101,730 | 23.09 | |
| 4mo | sched | 1 | $139,849 | 24.01 | |
| 4mo | sched | 1 | $132,472 | 24.41 | |
| 4mo | sell | 1 | $231,100 | 24.11 | |
| 4mo | sched | 1 | $137,700 | 24.11 | |
| 4mo | sched | 3 | $985,606 | 21.36 | |
| 4mo | sched | 2 | $98,344 | 18.61 | |
| 5mo | sched | 1 | $106,245 | 18.53 | |
| 5mo | sched | 1 | $119,220 | 19.24 | |
| 5mo | sched | 1 | $43,500 | 19.21 | |
| 5mo | sched | 1 | $41,344 | 19.20 | |
| 5mo | sell | 1 | $180,100 | 19.12 | |
| 6mo | sched | 1 | $103,436 | 19.39 | |
| 7mo | sell | 1 | $141,120 | 17.93 | |
| 7mo | sell | 1 | $103,398 | 17.77 | |
| 8mo | sell | 1 | $2,496 | 18.18 | |
| 8mo | sched | 1 | $97,951 | 18.27 | |
| 8mo | sell | 1 | $464,848 | 17.88 | |
| 8mo | sell | 1 | $179,186 | 19.75 | |
| 10mo | sched | 1 | $128,369 | 24.52 | |
| 10mo | sell | 6 | $352,976 | 14.62 | |
| 1.4y | sell | 1 | $9,176 | 4.66 | |
| 1.6y | buy | 1 | $58,400 | 5.68 | |
| 2.0y | sell | 1 | $1,491,029 | 9.29 | |
| 2.1y | sell | 1 | $7,395,656 | 5.88 | |
| 2.1y | sell | 1 | $3,404,761 | 5.95 | |
| 2.3y | sell | 1 | $6,166 | 3.87 | |
| 2.4y | sell | 1 | $4,876 | 4.11 | |
| 5.3y | buy | 16 | $276,750,010 | 21.09 |
Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS estimate -0.20. It has finished the next session higher 57% of the time, average move 5.8%.
Day-after move, last 12 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | miss | -0.37 | -0.43 | -17.6% | +0.1% | +0.6% | +1.5% |
| 2026-05-07 | miss | -0.38 | -0.45 | -19.1% | -0.7% | -2.8% | -8.4% |
| 2026-03-17 | miss | -0.34 | -0.55 | -63.4% | -1.3% | -2.0% | -10.0% |
| 2025-11-06 | beat | -0.35 | -0.33 | +6.4% | +0.7% | +5.7% | +16.3% |
| 2025-08-07 | beat | -0.38 | -0.15 | +60.2% | +0.3% | -2.9% | -0.1% |
| 2025-05-08 | beat | -0.32 | 0.57 | +277.0% | +18.7% | +9.6% | +0.5% |
| 2025-03-20 | beat | 0.03 | 0.27 | +902.6% | -3.6% | +5.4% | -21.5% |
| 2024-11-07 | beat | -0.47 | -0.29 | +38.4% | +0.5% | +0.8% | -10.3% |
| 2024-08-08 | beat | -0.54 | -0.43 | +20.5% | +6.4% | +10.2% | +35.7% |
| 2024-05-09 | beat | -0.58 | -0.53 | +8.2% | -0.4% | -1.5% | -0.8% |
| 2024-03-14 | miss | -0.39 | -0.58 | -49.8% | -1.5% | -8.4% | +14.1% |
| 2023-11-09 | beat | -0.74 | -0.70 | +5.7% | -0.5% | -10.6% | -12.2% |
| 2023-08-10 | miss | -0.69 | -0.71 | -2.7% | +1.2% | -1.6% | -6.0% |
| 2023-05-11 | beat | -0.68 | -0.65 | +5.1% | +3.5% | +1.0% | -4.3% |
| 2023-03-16 | miss | -0.62 | -0.63 | -1.3% | -2.5% | +7.4% | +6.6% |
| 2022-11-10 | beat | -0.59 | -0.58 | +2.2% | +3.6% | +5.3% | +22.0% |
| 2022-08-11 | miss | -0.47 | -0.57 | -20.4% | +8.4% | +5.2% | +4.6% |
| 2022-05-11 | beat | -0.54 | -0.51 | +5.9% | +1.6% | -16.0% | -13.3% |
| 2022-03-29 | beat | -0.51 | -0.11 | +78.2% | +1.0% | +16.3% | +29.3% |
| 2021-11-10 | beat | -0.44 | -0.43 | +2.1% | -0.5% | +4.1% | +0.1% |
| 2021-08-12 | miss | -0.38 | -3.63 | -842.9% | -2.0% | -3.9% | -0.8% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.9%
Next 1 week
+2.2%
Next 1 month
+2.4%
Mean reversion
Neutral — RSI(2) at 37
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.33%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 0.93 +2.3% · Seasonal tilt (4y) +0.0%
$16M/day volume
81% volatility
-14% 1-year
-76% from ATH
52-week range · 7% of the way up · -58% from the high
$9.68$25.77
Not investment advice.
Continue with Google